[et_pb_section fb_built=”1″ custom_padding_last_edited=”on|tablet” next_background_color=”#ffffff” admin_label=”Hero” _builder_version=”4.24.3″ use_background_color_gradient=”on” background_color_gradient_type=”circular” background_color_gradient_direction_radial=”top right” background_color_gradient_stops=”rgba(255,255,255,0) 20%|rgba(1,77,183,0.9) 100%” background_color_gradient_overlays_image=”on” background_color_gradient_start=”rgba(255,255,255,0)” background_color_gradient_start_position=”20%” background_color_gradient_end=”rgba(1,77,183,0.9)” background_image=”https:\/\/campbellneurosciences.com\/wp-content\/uploads\/2024\/06\/shutterstock_1028494843-scaled.jpg” custom_padding=”110px|0px|49px|0px|false|false” custom_padding_tablet=”50px||50px||true” custom_padding_phone=”|||” bottom_divider_style=”asymmetric” bottom_divider_height=”50px” bottom_divider_flip=”horizontal” bottom_divider_height_tablet=”90px” bottom_divider_height_phone=”80px” global_colors_info=”{}”][et_pb_row column_structure=”2_3,1_3″ _builder_version=”4.16″ custom_width_px=”1280px” global_colors_info=”{}”][et_pb_column type=”2_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][et_pb_text _builder_version=”4.24.3″ text_font=”Montserrat||||||||” text_text_color=”rgba(255,255,255,0.7)” text_font_size=”20px” text_line_height=”1.8em” header_font=”Montserrat|700|||||||” header_font_size=”44px” header_line_height=”1.4em” header_6_font=”Montserrat|600||on|||||” header_6_text_color=”rgba(255,255,255,0.7)” header_6_font_size=”16px” header_6_letter_spacing=”2px” header_6_line_height=”1.5em” background_layout=”dark” max_width=”780px” custom_margin=”-65px|||||” text_font_size_tablet=”” text_font_size_phone=”15px” text_font_size_last_edited=”on|phone” header_font_size_tablet=”” header_font_size_phone=”28px” header_font_size_last_edited=”on|phone” global_colors_info=”{}”]<\/p>\n
Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease.<\/span><\/p>\n [\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″ _builder_version=”4.16″ custom_padding=”|||” global_colors_info=”{}” custom_padding__hover=”|||”][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=”1″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_row _builder_version=”4.24.3″ _module_preset=”default” custom_margin=”-31px|auto||auto||” custom_padding=”0px|||||” global_colors_info=”{}”][et_pb_column type=”4_4″ _builder_version=”4.24.3″ _module_preset=”default” global_colors_info=”{}”][et_pb_text _builder_version=”4.24.3″ _module_preset=”default” hover_enabled=”0″ global_colors_info=”{}” sticky_enabled=”0″]<\/p>\n 05-09-2024 Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board<\/a><\/span> 03-27-2023 Biotechnology Veteran Dr. Thomas Ichim to Lead Suicide Prediction Company Campbell Neurosciences, Inc.<\/a><\/span> [\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":" Campbell Neurosciences, inc. Committed to establishing a biological basis for diagnosis and treatment of suicide and its causes, including Schizophrenia and other mental health disorders, thereby eliminating the stigma of the disease.05-09-2024 Immunology Based Suicide Prevention Company Campbell Neurosciences Announces Appointment of Public Company Veteran Raymond Oliver as Chairman of the Board04-03-2023 Therapeutic Solutions International […]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-130","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/130","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/comments?post=130"}],"version-history":[{"count":27,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/130\/revisions"}],"predecessor-version":[{"id":336,"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/pages\/130\/revisions\/336"}],"wp:attachment":[{"href":"https:\/\/campbellneurosciences.com\/index.php\/wp-json\/wp\/v2\/media?parent=130"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
04-03-2023 Therapeutic Solutions International Spin Off Campbell Neurosciences Announces Novel Mechanistic Data on CampbellCell Stem Cell Therapy for Schizophrenia<\/a><\/span><\/p>\n
03-20-2023 Therapeutic Solutions International Spin Off Campbell Neurosciences Creates Saliva Based Test for Suicidal Ideations<\/a><\/span>
01-23-2023 Therapeutic Solutions International Spin-Off Campbell Neurosciences Provides Progress Update in Quest for Addressing Suicide as a Medical Condition<\/a><\/span>
09-19-22 Therapeutic Solutions International Spin-Off Company Campbell Neurosciences Announces Successful Preclinical Studies of CampbellCell for Treatment of Bipolar Disorder<\/a><\/span>
02-14-22 Therapeutic Solutions International Spin-Off Campbell Neurosciences Announces Positive Preclinical Safety and Efficacy Data Using CampbellCell\u2122 for Treatment of Schizophrenia<\/a><\/span>
08-20-21 Therapeutic Solutions International Announces Titan of Industry Dr. Peter Farrell Joins Advisory Board of its Suicide Prevention Spin-Off Campbell Neurosciences<\/a><\/span>
07-08-21 Therapeutic Solutions International Spin-Off Campbell Neurosciences Explains Why Suicide is a Disease and How to Predict it in Newly Released Video<\/a><\/span>
07-02-21 Therapeutic Solutions International Spin-Off Campbell Neurosciences Initiates Pilot Implementation of Campbell Score\u2122 with California Concierge Medical & Wellness Inc.<\/a><\/span>
06-16-21 Campbell Neurosciences Spin Off of Therapeutic Solutions Reports Synergistic Reduction of Schizophrenia in Animal Models using Low Dose Naltrexone and T Regulatory Cell Stimulation<\/a><\/span>
06-10-21 Therapeutic Solutions International Spinoff Campbell Neurosciences Reports Reduction of Schizophrenia Activity in Mice Subsequent to Administration of Tolerogenic Dendritic Cells<\/a><\/span>
06-02-21 Therapeutic Solutions International Subsidiary Campbell Neurosciences Identifies T Regulatory Cells as a Mechanism of Stem Cell Suppression of Schizophrenia Pathology in an Animal Model<\/a><\/span>
05-17-21 Therapeutic Solutions International and Campbell Neurosciences Announce Preclinical Studies Showing Low Doses of FDA Cleared Immune Stimulant Interleukin-2 Reduces Inflammation Associated Depression in Animal Model<\/a><\/span>
05-10-21 Therapeutic Solutions International Subsidiary Campbell Neurosciences Reports Positive Preclinical Data in Animal Model of Schizophrenia Using Proprietary Universal Donor Mesenchymal<\/a> Stem Cell<\/span>
04-19-21 Therapeutic Solutions International Spin-Off Campbell Neurosciences Identifies Mechanism of Action for Umbilical Cord Blood Derived NarcoStem\u2122 Drug Rehabilitation Product<\/a><\/span>
04-13-21 Therapeutic Solutions International with Subsidiary Campbell Neurosciences Develops Cord Blood Based Inhalable Product for Opioid Addiction<\/a><\/span>
03-04-21 Therapeutic Solutions International Spin-off Campbell Neurosciences Announces Umbilical Cord Derived Monocyte Immunotherapy Candidate for Suicide Prevention<\/a><\/span>
02-25-21 Therapeutic Solutions International Spin-Off Campbell Neurosciences Demonstrates Preliminary Efficacy of First Blood-Based Test for Gambling Addiction: Kaihani Score\u2122<\/a><\/span>
01-13-21 Therapeutic Solutions International Announces Positive Early Clinical Data from Ongoing Suicidal Ideation Blood Biomarker Clinical Trial with Spinoff Campbell Neurosciences<\/a><\/span>
12-31-20 Therapeutic Solutions International Launches Campbell Neurosciences Inc as First Suicide Focused Regenerative Psychiatry Biotechnology Company<\/a><\/span>
12-21-20 Therapeutic Solutions International Files Patent on NeuroLeukin\u2122 Personalized Immunotherapy for Opioid Addiction<\/a><\/span>
12-09-20 Therapeutic Solutions International Division of Campbell Neurosciences Files Patent on QuadraMune\u2122 for Treatment of Major Depressive Disorder<\/a><\/span>
12-02-20 Therapeutic Solutions International Announces Clinical Trial Assessing \u201cKaihani Score\u201d Proprietary Biomarker Based Assay for Quantifying Gambling Addiction<\/a><\/span>
10-29-20 Therapeutic Solutions International Launches Clinical Trial to Validate First Blood Based Predicator of Suicidal Ideation: The Campbell Score\u2122<\/a><\/span>
10-05-20 Therapeutic Solutions International announced today appointment of J Christopher Mizer to the Advisory Board of its Campbell Neurosciences Division<\/a><\/span>
09-24-20 Therapeutic Solutions International Announces Proof of Concept Data and Patent Filing for Neuroleukin\u2122: The First Immune Based Suicide Prevention Biological Therapy<\/a><\/span>
09-14-20 Therapeutic Solutions International Files Comprehensive Campbell Platform\u2122 Patent for Stem Cell Immunotherapy of Schizophrenia<\/a><\/span>
08-28-20 Therapeutic Solutions International Reports Synergistic Suppression of Suicide-Associated Neuroinflammatory Pathway by QuadraMune\u2122 and Minocycline<\/a><\/span>
08-21-20 Therapeutic Solutions International Files Patent on Campbell Score\u2122: The First Quantitative Tool for Assessment of Suicidal Propensity based on Immunological Markers<\/a><\/span>
08-11-20 Therapeutic Solutions International Launches Campbell Neurosciences Division aimed at Biologically Identifying and Repairing Suicide-Prone Brains<\/a><\/span><\/p>\n